Skip to content
TriangleGet started
← Childhood Myelodysplastic Neoplasms

FOR PATIENTS · SOURCE READING

Treatment of Childhood Myelodysplastic Syndromes

Source: Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: June 5, 2024 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

Childhood MDS source section; source uses syndromes wording Only the named source sections and descendants are joined. Parent source is broader; original patient terminology and grade/setting constraints must remain visible.

For information about the treatments listed below, see the Treatment Option Overview section.

Source links and citations

Treatment of newly diagnosed childhood myelodysplastic syndromes (MDS) may include the following:

Source links and citations

Stem cell transplant using blood stem cells from a donor.

Source links and citations

Supportive care, including transfusion therapy and antibiotics.

Source links and citations

Steroid therapy.

Source links and citations

Lenalidomide therapy, for patients with certain gene changes.

Source links and citations

If the MDS becomes acute myeloid leukemia (AML), treatment will be the same as treatment for newly diagnosed AML.

Source links and citations

Preserved source evidence · Independent clinical review pending · Not medical advice